Alcami Expands Presence on DCAT's Board of Directors and Advisory Council

DCAT_Logo.pngAlcami is pleased to be expanding its presence on the 2017-2018 Drug, Chemical & Associated Technologies Association (DCAT) Board of Directors and Advisory Council. The elected members began their terms on November 1, 2017.

Dr. Stephan Kutzer, CEO, President and Chairman of Alcami Corporation begins his second term on the board as Second Vice President, having previously served as Third Vice President. It is the role of the board to work on developing and guiding the organization's strategic plan, establishing and implementing policy, and managing financial matters for member companies.

Syed T. Husain, Chief Commercial Officer of Alcami Corporation has been newly appointed to the DCAT Advisory Council. The newly elected members are charged with providing insights, guidance and expertise to the Board of Directors, as well as to the committees and task forces upon which they serve.

DCAT is an industry organization that powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development and manufacturing.

Topics: Company News